Cite
APA Citation
Yazici, Y., Xie, L., Ogbomo, A., Parenti, D., Goyal, K., Teeple, A., Ellis, L., & Simsek, I. (n.d.). sAT0175 A descriptive analysis of real-world treatment patterns in a turkish rheumatology population that continued innovator infliximab (REMICADE) therapy or switched to biosimilar infliximab. Annals of the rheumatic diseases, 76, 836. http://access.bl.uk/ark:/81055/vdc_100135163686.0x000060